News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,537 Results
Type
Article (41731)
Company Profile (464)
Press Release (659342)
Section
Business (208452)
Career Advice (2005)
Deals (35957)
Drug Delivery (92)
Drug Development (83335)
Employer Resources (169)
FDA (16331)
Job Trends (15050)
News (352199)
Policy (32994)
Tag
Academia (2623)
Alliances (50615)
Alzheimer's disease (1277)
Approvals (16256)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11741)
Biotechnology (350)
Breast cancer (124)
Cancer (1121)
Cardiovascular disease (102)
Career advice (1673)
Cell therapy (250)
Clinical research (66038)
Collaboration (409)
Compensation (202)
COVID-19 (2590)
C-suite (100)
Data (1145)
Diabetes (156)
Diagnostics (6198)
Earnings (86083)
Employer resources (147)
Events (112982)
Executive appointments (316)
FDA (16882)
Funding (371)
Gene therapy (194)
GLP-1 (613)
Government (4411)
Healthcare (19006)
Infectious disease (2675)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16589)
Job creations (3696)
Job search strategy (1429)
Layoffs (439)
Legal (7930)
Lung cancer (174)
Manufacturing (181)
Medical device (13357)
Medtech (13362)
Mergers & acquisitions (19438)
Metabolic disorders (427)
Neuroscience (1568)
NextGen Class of 2024 (6736)
Non-profit (4533)
Northern California (1501)
Obesity (246)
Opinion (198)
Patents (103)
People (57641)
Phase I (20694)
Phase II (29150)
Phase III (21559)
Pipeline (462)
Postmarket research (2593)
Preclinical (8887)
Radiopharmaceuticals (252)
Rare diseases (235)
Real estate (5999)
Regulatory (21975)
Research institute (2406)
Resumes & cover letters (351)
Southern California (1329)
Startups (3750)
United States (13932)
Vaccines (566)
Weight loss (184)
Date
Today (79)
Last 7 days (684)
Last 30 days (3807)
Last 365 days (36775)
2024 (33766)
2023 (41016)
2022 (52292)
2021 (56780)
2020 (54941)
2019 (47443)
2018 (35722)
2017 (33041)
2016 (32362)
2015 (38405)
2014 (32197)
2013 (27139)
2012 (29234)
2011 (29884)
2010 (28023)
Location
Africa (731)
Arizona (201)
Asia (38545)
Australia (6405)
California (3432)
Canada (1302)
China (257)
Colorado (151)
Connecticut (163)
Europe (84070)
Florida (465)
Georgia (116)
Illinois (354)
Indiana (199)
Kansas (99)
Maryland (590)
Massachusetts (2736)
Michigan (160)
Minnesota (279)
New Jersey (975)
New York (980)
North Carolina (760)
Northern California (1501)
Ohio (141)
Pennsylvania (856)
South America (1106)
Southern California (1329)
Texas (481)
Utah (92)
Washington State (377)
701,537 Results for "cerebral therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Beach
SpineX Announces Successful in-Human Results to Treat Adults with Cerebral Palsy
SpineX Inc. today announced groundbreaking results in its first in-human study treating an adult with Cerebral Palsy (CP).
January 3, 2024
·
2 min read
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Ovid Therapeutics Inc. and Graviton Bioscience Corporation today announced the results from their Phase 1 healthy volunteer study evaluating the safety, tolerability, and pharmacokinetic (PK) profile of multiple ascending doses of OV888/GV101 capsule.
July 1, 2024
·
9 min read
Press Releases
Doheny Eye Institute To Receive Funding from NIH Award Supporting Cerebral Small Vessel Disease Detection
October 3, 2024
·
6 min read
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
BioMidwest
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India for Acute Cerebral Ischemic Stroke Patients
Pharmazz, Inc. (“Pharmazz” or the “Company”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care, announced that The Directorate General of Health Services, India on May 31st, 2023, granted the manufacture and marketing of Sovateltide Injection for cerebral ischemic stroke patients.
May 31, 2023
·
2 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
1 of 70,154
Next
